Dzotsi Marissa, Strohm Allyssa, Varshney Shweta, Zuniga-Hertz Juan P, Chitteti Ramamurthy, Manoogian Emily, Sethi Anshika, Panda Satchidananda, Patel Hemal H, Doherty Taylor A, Taub Pam
UC San Diego School of Medicine, La Jolla, CA.
Salk Institute for Biological Studies, Regulatory Biology, La Jolla, CA.
medRxiv. 2025 May 31:2025.05.29.25328448. doi: 10.1101/2025.05.29.25328448.
Postural orthostatic tachycardia syndrome (POTS) is characterized by an abnormal increase in heart rate upon standing, leading to symptoms such as dizziness, fatigue, and rapid heart rate. Time-restricted eating (TRE), which limits caloric intake to an 8-10 hour daily window, has been shown to decrease inflammation and improve immune, autonomic, and mitochondrial function, as well as cardiometabolic parameters. This single arm pilot study evaluated the effects of TRE on quality of life (QOL), heart rate, and mitochondrial function in 20 participants with POTS (≥30 bpm increase in upright heart rate) and a baseline dietary window of ≥12 hours. Following a 2-week baseline monitoring period, participants underwent a 12-week TRE intervention. Pre- and post-intervention assessments included QOL questionnaires, a 10-minute stand test, and plasma mitochondrial analysis. TRE significantly reduced heart rate increase upon standing (mean decrease: 11 bpm, p < 0.001), improved QOL metrics including POTS symptom severity (p < 0.0001), physical functioning (p = 0.02), and energy/fatigue (p < 0.01), and increased mitochondrial-derived ATP. These findings suggest TRE as a promising lifestyle intervention to improve QOL, heart rate, and mitochondrial function in POTS patients.
体位性直立性心动过速综合征(POTS)的特征是站立时心率异常增加,导致头晕、疲劳和心率加快等症状。限时进食(TRE)将热量摄入限制在每天8至10小时的时间段内,已被证明可减少炎症并改善免疫、自主神经和线粒体功能以及心脏代谢参数。这项单臂试点研究评估了TRE对20名POTS患者(直立心率增加≥30次/分钟)和基线饮食时间段≥12小时的生活质量(QOL)、心率和线粒体功能的影响。在为期2周的基线监测期后,参与者接受了为期12周的TRE干预。干预前后的评估包括QOL问卷、10分钟站立测试和血浆线粒体分析。TRE显著降低了站立时的心率增加(平均降低:11次/分钟,p<0.001),改善了QOL指标,包括POTS症状严重程度(p<0.0001)、身体功能(p=0.02)和能量/疲劳(p<0.01),并增加了线粒体衍生的ATP。这些发现表明TRE作为一种有前景的生活方式干预措施,可改善POTS患者的QOL、心率和线粒体功能。